Besides providing a pro-inflammatory status by interaction with DCs, NK and CTL, iNKT have also been found to be able to control tumor growth by killing tumor supportive IL-6-producing CD1d+ CD68+ tumor associated macrophages (TAM) (78). Here, CD1D is linked to neoplasm.